CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +8,671 | $11.10 | $96K | 31,492 |
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +1,157 | $17.76 | $21K | 32,649 |
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −23,234 | $28.02 | $651K | 9,415 |
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −13,406 | 27,594 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −8,671 | 21,059 | ||
| 2025-05-01 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise · Share Option 10b5-1 | −1,157 | 37,511 | ||
| 2025-05-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +12,000 | $17.92 | $215K | 39,009 |
| 2025-05-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +13,141 | $17.76 | $233K | 52,150 |
| 2025-05-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −25,141 | $27.80 | $699K | 27,009 |
| 2025-05-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −12,000 | 0 | ||
| 2025-05-01 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −13,141 | 28,909 | ||
| 2025-04-30 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +21,254 | $16.90 | $359K | 48,263 |
| 2025-04-30 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −21,254 | $26.95 | $573K | 27,009 |
| 2025-04-30 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −21,254 | 2,471 | ||
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +15,000 | $15.52 | $233K | 24,415 |
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +20,000 | $15.50 | $310K | 44,415 |
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +6,296 | $12.97 | $82K | 50,711 |
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +7,432 | $11.97 | $89K | 58,143 |
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Option exercise 10b5-1 | +15,307 | $10.76 | $165K | 73,450 |
| 2025-04-29 | Moat Ross CHIEF COMMERCIAL OFFICER | Sale 10b5-1 | −64,035 | $25.21 | $1.6M | 9,415 |
Page 36 of 74 · 1,467 trades